News

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...
The US health department's Biomedical Advanced Research and Development Authority is "terminating 22 mRNA vaccine development ...
The measles vaccine was so effective that the disease was considered eliminated in the U.S., but a resurgence of outbreaks is ...
The vaccine that could lower the risk of dementia by 20 per cent - A new study could change the way we understand and treat ...
The biggest concern with rubella is in reproductive-age women, who are very likely to have a child with birth defects if they ...
Unit 371 at Illinois Masonic Hospital was a major treatment center for AIDS and inspired similar wards in Chicago and across ...
CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on ...
Real-world analysis of the first season of vaccination against RSV has shown a dramatic impact on hospitalisation.
The US Food and Drug Administration (FDA) has lifted a pause in the use of Valneva’s chikungunya vaccine Ixchiq in older adults after a benefit-risk reevaluation, though the move comes with an ...
The NHS is urging pregnant women from 28 weeks to get vaccinated against RSV to protect their babies this winter.
Public health officials are encouraging parents to get their children vaccinated before they return to school next month.
Connecticut led the nation with 98.3 percent of its kindergarteners vaccinated against measles, mumps, and rubella.Experts said that was the highest rate in the country, and a 0.5-point gain from last ...